BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36824150)

  • 1. Risk Evaluation of Bone Metastases and a Simple Tool for Detecting Bone Metastases in Prostate Cancer: A Population-Based Study.
    Li S; Chen C; Zhu H; Lin Q; Yu Z
    Comput Math Methods Med; 2023; 2023():9161763. PubMed ID: 36824150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of non-regional lymph nodes in assigning risk in primary metastatic prostate cancer.
    Ali A; Hoyle A; Mistry H; Clarke NW
    BJU Int; 2019 Jan; 123(1):65-73. PubMed ID: 29777564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
    Wenger H; Weiner AB; Razmaria A; Paner GP; Eggener SE
    Urol Oncol; 2017 Jan; 35(1):31.e1-31.e6. PubMed ID: 27692833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Prostate-specific Antigen Persistence After Radical Prostatectomy for the Prediction of Clinical Progression and Cancer-specific Mortality in Node-positive Prostate Cancer Patients.
    Bianchi L; Nini A; Bianchi M; Gandaglia G; Fossati N; Suardi N; Moschini M; Dell'Oglio P; Schiavina R; Montorsi F; Briganti A
    Eur Urol; 2016 Jun; 69(6):1142-8. PubMed ID: 26749093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence proportions and prognosis of breast cancer patients with bone metastases at initial diagnosis.
    Gong Y; Zhang J; Ji P; Ling H; Hu X; Shao ZM
    Cancer Med; 2018 Aug; 7(8):4156-4169. PubMed ID: 29984914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting survival in node-positive prostate cancer after open, laparoscopic or robotic radical prostatectomy: A competing risk analysis of a multi-institutional database.
    Schiavina R; Bianchi L; Borghesi M; Briganti A; Brunocilla E; Carini M; Terrone C; Mottrie A; Dente D; Gacci M; Gontero P; Gurioli A; Imbimbo C; La Manna G; Marchioro G; Milanese G; Mirone V; Montorsi F; Morgia G; Munegato S; Novara G; Panarello D; Porreca A; Russo GI; Serni S; Simonato A; Urzì D; Verze P; Volpe A; Martorana G
    Int J Urol; 2016 Dec; 23(12):1000-1008. PubMed ID: 27620370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer.
    Schmidkonz C; Cordes M; Beck M; Goetz TI; Schmidt D; Prante O; Bäuerle T; Uder M; Wullich B; Goebell P; Kuwert T; Ritt P
    Clin Nucl Med; 2018 Apr; 43(4):225-231. PubMed ID: 29401151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is computed tomography a necessary part of a metastatic evaluation for castration-resistant prostate cancer? Results from the Shared Equal Access Regional Cancer Hospital Database.
    Hanyok BT; Howard LE; Amling CL; Aronson WJ; Cooperberg MR; Kane CJ; Terris MK; Posadas EM; Freedland SJ
    Cancer; 2016 Jan; 122(2):222-9. PubMed ID: 26484853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup.
    Palapattu GS; Allaf ME; Trock BJ; Epstein JI; Walsh PC
    J Urol; 2004 Nov; 172(5 Pt 1):1860-4. PubMed ID: 15540739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional Lymph Node Involvement Is Associated With Poorer Survivorship in Patients With Chondrosarcoma: A SEER Analysis.
    Wan L; Tu C; Li S; Li Z
    Clin Orthop Relat Res; 2019 Nov; 477(11):2508-2518. PubMed ID: 31283732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of the Site of Metastases on Survival in Patients with Metastatic Prostate Cancer.
    Gandaglia G; Karakiewicz PI; Briganti A; Passoni NM; Schiffmann J; Trudeau V; Graefen M; Montorsi F; Sun M
    Eur Urol; 2015 Aug; 68(2):325-34. PubMed ID: 25108577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contemporary Incidence and Outcomes of Prostate Cancer Lymph Node Metastases.
    Bernstein AN; Shoag JE; Golan R; Halpern JA; Schaeffer EM; Hsu WC; Nguyen PL; Sedrakyan A; Chen RC; Eggener SE; Hu JC
    J Urol; 2018 Jun; 199(6):1510-1517. PubMed ID: 29288121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma.
    Sinha AA; Quast BJ; Wilson MJ; Fernandes ET; Reddy PK; Ewing SL; Gleason DF
    Cancer; 2002 Jun; 94(12):3141-9. PubMed ID: 12115346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
    Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
    Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I collagen biomarkers in the diagnosis of bone metastases in breast cancer, lung cancer, urinary bladder cancer and prostate cancer. Comparison to CEA, CA 15-3, PSA and bone scintigraphy.
    Zissimopoulos A; Stellos K; Matthaios D; Petrakis G; Parmenopoulou V; Babatsikou F; Matthaiou E; Theodosiadou E; Hountis P; Koutis C
    J BUON; 2009; 14(3):463-72. PubMed ID: 19810140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognosis of prostate cancer and bone metastasis pattern of patients: a SEER-based study and a local hospital based study from China.
    Liu D; Kuai Y; Zhu R; Zhou C; Tao Y; Han W; Chen Q
    Sci Rep; 2020 Jun; 10(1):9104. PubMed ID: 32499554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial Sarcoma Is Not Associated With a Higher Risk of Lymph Node Metastasis Compared With Other Soft Tissue Sarcomas.
    Jacobs AJ; Morris CD; Levin AS
    Clin Orthop Relat Res; 2018 Mar; 476(3):589-598. PubMed ID: 29529647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural history of rising serum prostate-specific antigen in men with castrate nonmetastatic prostate cancer.
    Smith MR; Kabbinavar F; Saad F; Hussain A; Gittelman MC; Bilhartz DL; Wynne C; Murray R; Zinner NR; Schulman C; Linnartz R; Zheng M; Goessl C; Hei YJ; Small EJ; Cook R; Higano CS
    J Clin Oncol; 2005 May; 23(13):2918-25. PubMed ID: 15860850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognosis of different distant metastases pattern in prostate cancer: A population based retrospective study.
    Shou J; Zhang Q; Wang S; Zhang D
    Prostate; 2018 May; 78(7):491-497. PubMed ID: 29436722
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.